Nuzenio

Attr

Attr news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Will Phase III lonvo-z Data and Resumed ATTR Program Change Intellia Therapeutics' (NTLA) Narrative - simplywall.stsimplywall.st · Fri, 07 Aug 2026 13:40:06 GMTIntellia finds genetic suspect for liver safety signals with ATTR gene therapy - biospace.combiospace.com · Fri, 07 Aug 2026 12:57:59 GMTCardiology clinical trials reinforce Attruby in ATTR-CM while GLP-1s and CHAMPION-AF shape the future of cardiovascular care - EU ReporterEU Reporter · Thu, 06 Aug 2026 08:04:38 GMTAlnylam shares tank 29% as Amvuttra disappoints with ATTR outlook cut for 2026 - fiercepharma.comfiercepharma.com · Thu, 30 Jul 2026 07:00:00 GMTAlnylam Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Period Progress - AlnylamAlnylam · Thu, 30 Jul 2026 07:00:00 GMTAcoramidis Attenuates Decline in Heart Failure–Related Health Status in ATTR-CM - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Wed, 29 Jul 2026 15:06:16 GMT

Timeline

Fri, 07 Aug 2026 13:40:06 GMTWill Phase III lonvo-z Data and Resumed ATTR Program Change Intellia Therapeutics' (NTLA) Narrative - simplywall.st
Fri, 07 Aug 2026 12:57:59 GMTIntellia finds genetic suspect for liver safety signals with ATTR gene therapy - biospace.com
Thu, 06 Aug 2026 08:04:38 GMTCardiology clinical trials reinforce Attruby in ATTR-CM while GLP-1s and CHAMPION-AF shape the future of cardiovascular care - EU Reporter
Thu, 30 Jul 2026 07:00:00 GMTAlnylam shares tank 29% as Amvuttra disappoints with ATTR outlook cut for 2026 - fiercepharma.com
Thu, 30 Jul 2026 07:00:00 GMTAlnylam Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Period Progress - Alnylam
Wed, 29 Jul 2026 15:06:16 GMTAcoramidis Attenuates Decline in Heart Failure–Related Health Status in ATTR-CM - The American Journal of Managed Care® (AJMC®)

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Attr.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.